Status:
WITHDRAWN
T-Cell PET Imaging With [18F]F-AraG in Lung Cancer
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
CellSight Technologies, Inc.
Conditions:
Non-small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This is a single-center cross-sectional imaging study in patients with localized lung cancer undergoing immunotherapy with or without stereotactic radiation therapy as part of the companion clinical t...
Detailed Description
This is a single-center cross-sectional imaging study in patients with localized lung cancer undergoing immunotherapy with or without stereotactic radiation therapy as part of the companion clinical t...
Eligibility Criteria
Inclusion
- Age greater than or equal to 18 years
- Histologically or cytologically documented stage I-IIIA non-small cell lung cancer (NSCLC)
- Eligible for with plan to undergo immunotherapy alone or both immunotherapy and stereotactic radiation therapy as part of NCT03217071
- In female patients, negative pregnancy test with no plans to become pregnant during the duration of the study
- Able to provide informed consent and follow the study guidelines
Exclusion
- 1\. Female patients who are pregnant or breastfeeding
Key Trial Info
Start Date :
November 26 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 15 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03311672
Start Date
November 26 2017
End Date
October 15 2019
Last Update
October 21 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.